- Home
- DCTH vs CHW Comparison
DCTH vs CHW Comparison
Compare DCTH & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- CHW
- Stock Information
- Founded
- DCTH 1988
- CHW 2007
- Country
- DCTH United States
- CHW United States
- Employees
- DCTH N/A
- CHW N/A
- Industry
- DCTH Medical/Dental Instruments
- CHW Investment Managers
- Sector
- DCTH Health Care
- CHW Finance
- Exchange
- DCTH Nasdaq
- CHW Nasdaq
- Market Cap
- DCTH 388.3M
- CHW 459.2M
- IPO Year
- DCTH N/A
- CHW N/A
- Fundamental
- Price
- DCTH $10.67
- CHW $7.48
- Analyst Decision
- DCTH Strong Buy
- CHW
- Analyst Count
- DCTH 4
- CHW 0
- Target Price
- DCTH $24.50
- CHW N/A
- AVG Volume (30 Days)
- DCTH 485.5K
- CHW 195.2K
- Earning Date
- DCTH 11-07-2025
- CHW 01-01-0001
- Dividend Yield
- DCTH N/A
- CHW 9.27%
- EPS Growth
- DCTH N/A
- CHW N/A
- EPS
- DCTH 0.06
- CHW N/A
- Revenue
- DCTH $70,240,000.00
- CHW N/A
- Revenue This Year
- DCTH $159.22
- CHW N/A
- Revenue Next Year
- DCTH $41.22
- CHW N/A
- P/E Ratio
- DCTH $193.75
- CHW N/A
- Revenue Growth
- DCTH 491.35
- CHW N/A
- 52 Week Low
- DCTH $8.08
- CHW $5.07
- 52 Week High
- DCTH $18.23
- CHW $6.54
- Technical
- Relative Strength Index (RSI)
- DCTH 43.30
- CHW 69.59
- Support Level
- DCTH $10.60
- CHW $7.20
- Resistance Level
- DCTH $11.38
- CHW $7.51
- Average True Range (ATR)
- DCTH 0.44
- CHW 0.08
- MACD
- DCTH 0.01
- CHW 0.02
- Stochastic Oscillator
- DCTH 5.26
- CHW 90.91
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.